Generation of mutator mutants during carcinogenesis.

[1]  T. Kunkel,et al.  Low-fidelity DNA synthesis by human DNA polymerase theta , 2008, Nucleic acids research.

[2]  S. Webb.  A Patient’s Journey : Xeroderma pigmentosum , 2008 .

[3]  C. Vaziri,et al.  DNA Polymerase κ Is Specifically Required for Recovery from the Benzo[a]pyrene-Dihydrodiol Epoxide (BPDE)-induced S-phase Checkpoint* , 2005, Journal of Biological Chemistry.

[4]  M. Albertella,et al.  The overexpression of specialized DNA polymerases in cancer. , 2005, DNA repair.

[5]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[6]  J. Bielas,et al.  Quantification of random genomic mutations , 2005, Nature Methods.

[7]  D. Gilliland,et al.  Leukaemia stem cells and the evolution of cancer-stem-cell research , 2005, Nature Reviews Cancer.

[8]  Z. Livneh,et al.  Quantitative Analysis of Translesion DNA Synthesis across a Benzo[a]pyrene-Guanine Adduct in Mammalian Cells , 2004, Journal of Biological Chemistry.

[9]  U. Hübscher,et al.  The DNA-polymerase-X family: controllers of DNA quality? , 2004, Nature Reviews Molecular Cell Biology.

[10]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[11]  N. Rahman,et al.  Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B , 2004, Nature Genetics.

[12]  J. Venables.  Aberrant and Alternative Splicing in Cancer , 2004, Cancer Research.

[13]  M. Goodman,et al.  To Slip or Skip, Visualizing Frameshift Mutation Dynamics for Error-prone DNA Polymerases* , 2004, Journal of Biological Chemistry.

[14]  G. Maga,et al.  Human DNA polymerases lambda and beta show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation. , 2004, Biochemistry.

[15]  M. Nussenzweig,et al.  AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.

[16]  G. Maga,et al.  De novo DNA synthesis by human DNA polymerase lambda, DNA polymerase mu and terminal deoxyribonucleotidyl transferase. , 2004, Journal of molecular biology.

[17]  J. Sweasy,et al.  Is There a Link Between DNA Polymerase Beta and Cancer? , 2004, Cell cycle.

[18]  T. Kunkel.  DNA Replication Fidelity* , 2004, Journal of Biological Chemistry.

[19]  M. Lai,et al.  Hepatitis C virus induces a mutator phenotype: Enhanced mutations of immunoglobulin and protooncogenes , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[21]  Z. Livneh,et al.  Lesion Bypass by Human DNA Polymerase μ Reveals a Template-dependent, Sequence-independent Nucleotidyl Transferase Activity* , 2004, Journal of Biological Chemistry.

[22]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Naldini,et al.  Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR. , 2003, Nucleic acids research.

[24]  T. Kunkel,et al.  The Frameshift Infidelity of Human DNA Polymerase λ , 2003, Journal of Biological Chemistry.

[25]  Martin A. Nowak,et al.  The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.

[26]  E. G. Frank,et al.  129-derived Strains of Mice Are Deficient in DNA Polymerase ι and Have Normal Immunoglobulin Hypermutation , 2003, The Journal of experimental medicine.

[27]  Kevin R Coombes,et al.  High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. , 2003, Blood.

[28]  Y. Oka,et al.  Multiple tumors in mitochondrial diabetes associated with tRNALeu(UUR) mutation at position 3264. , 2003, Diabetes care.

[29]  F. Vuillier,et al.  Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. , 2003, Blood.

[30]  N. Kakazu,et al.  Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.

[31]  W. Klapper,et al.  Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. , 2003, Blood.

[32]  S. Anant,et al.  Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer? , 2003, Trends in molecular medicine.

[33]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Loeb,et al.  Multiple mutations and cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Fodde,et al.  Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling , 2002, Nature Genetics.

[36]  L. Prakash,et al.  Role of human DNA polymerase κ as an extender in translesion synthesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Yanbin Zhang,et al.  Lesion Bypass Activities of Human DNA Polymerase μ* , 2002, The Journal of Biological Chemistry.

[38]  Y. Shinkai,et al.  Polκ protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Reuben S Harris,et al.  RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.

[40]  J. Weill,et al.  Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota , 2002, Nature.

[41]  E. Friedberg,et al.  Human DNA Polymerase κ Bypasses and Extends beyond Thymine Glycols during Translesion Synthesis in Vitro, Preferentially Incorporating Correct Nucleotides* , 2002, The Journal of Biological Chemistry.

[42]  Alberto Martin,et al.  Somatic hypermutation of the AID transgene in B and non-B cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Yanbin Zhang,et al.  trans-Lesion Synthesis Past Bulky Benzo[a]pyrene Diol Epoxide N 2-dG and N 6-dA Lesions Catalyzed by DNA Bypass Polymerases* , 2002, The Journal of Biological Chemistry.

[44]  J. Cairns.  Somatic stem cells and the kinetics of mutagenesis and carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Neuberger,et al.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.

[46]  M. Radman,et al.  Specialized DNA Polymerases, Cellular Survival, and the Genesis of Mutations , 2002, Science.

[47]  L. Blanco,et al.  Human DNA polymerase mu (Pol mu) exhibits an unusual replication slippage ability at AAF lesion. , 2002, Nucleic acids research.

[48]  J. Stringer,et al.  Embryonic stem cells and somatic cells differ in mutation frequency and type , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Bodmer,et al.  How many mutations in a cancer? , 2002, The American journal of pathology.

[50]  Giovanni Parmigiani,et al.  Prevalence of somatic alterations in the colorectal cancer cell genome , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Alberto Martin,et al.  Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas , 2002, Nature.

[52]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[53]  Yanbin Zhang,et al.  Highly Frequent Frameshift DNA Synthesis by Human DNA Polymerase μ , 2001, Molecular and Cellular Biology.

[54]  A. Duval,et al.  Conservation of mononucleotide repeats within 3′ and 5′ untranslated regions and their instability in MSI-H colorectal cancer , 2001, Oncogene.

[55]  F. Amaldi,et al.  A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency , 2001, Oncogene.

[56]  Z. Livneh.  DNA Damage Control by Novel DNA Polymerases: Translesion Replication and Mutagenesis* , 2001, The Journal of Biological Chemistry.

[57]  S. Seneca,et al.  A new mitochondrial point mutation in the transfer RNA(Leu) gene in a patient with a clinical phenotype resembling Kearns-Sayre syndrome. , 2001, Archives of neurology.

[58]  A. Jackson,et al.  The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. , 2001, Mutation research.

[59]  F. Hanaoka,et al.  Translesion DNA Synthesis Catalyzed by Human Pol η and Pol κ across 1,N 6-Ethenodeoxyadenosine* , 2001, The Journal of Biological Chemistry.

[60]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[61]  J. Yokota,et al.  Somatic mutations and single nucleotide polymorphisms of base excision repair genes involved in the repair of 8-hydroxyguanine in damaged DNA. , 2001, Cancer letters.

[62]  Robert E. Johnson,et al.  Roles of yeast DNA polymerases delta and zeta and of Rev1 in the bypass of abasic sites. , 2001, Genes & development.

[63]  R. Sciot,et al.  The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases. , 2001, The American journal of pathology.

[64]  Fenghua Yuan,et al.  Response of human DNA polymerase ι to DNA lesions , 2001 .

[65]  William J. Feaver,et al.  Purification and Characterization of polκ, a DNA Polymerase Encoded by the Human DINB1 Gene* , 2001, The Journal of Biological Chemistry.

[66]  M. Yamaizumi,et al.  Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation. , 2000, The Journal of investigative dermatology.

[67]  Fenghua Yuan,et al.  Error-free and error-prone lesion bypass by human DNA polymerase κ in vitro , 2000 .

[68]  M. Goodman,et al.  The expanding polymerase universe , 2000, Nature Reviews Molecular Cell Biology.

[69]  J P McDonald,et al.  Misinsertion and bypass of thymine–thymine dimers by human DNA polymerase ι , 2000, The EMBO journal.

[70]  Fenghua Yuan,et al.  Preferential Incorporation of G Opposite Template T by the Low-Fidelity Human DNA Polymerase ι , 2000, Molecular and Cellular Biology.

[71]  M. Taniwaki,et al.  Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. , 2000, Genomics.

[72]  F. Hanaoka,et al.  Mechanisms of accurate translesion synthesis by human DNA polymerase η , 2000, The EMBO journal.

[73]  Chikahide Masutani,et al.  Low fidelity DNA synthesis by human DNA polymerase-η , 2000, Nature.

[74]  F. Hanaoka,et al.  Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. , 2000, Biochemistry.

[75]  P. Duesberg,et al.  Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Robert E. Johnson,et al.  Accuracy of thymine-thymine dimer bypass by Saccharomyces cerevisiae DNA polymerase eta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[77]  T. Honjo,et al.  Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.

[78]  Chikahide Masutani,et al.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.

[79]  P. Duesberg,et al.  Genetic instability of cancer cells is proportional to their degree of aneuploidy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[81]  A. Jackson,et al.  The mutation rate and cancer. , 1998, Genetics.

[82]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[83]  K. Ohshima,et al.  TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE STAINING OF MALIGNANT LYMPHOMAS IN PARAFFIN SECTIONS: A USEFUL METHOD FOR THE DIAGNOSIS OF LYMPHOBLASTIC LYMPHOMA , 1997, The Journal of pathology.

[84]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[85]  M. Loda,et al.  Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. , 1997, Cancer research.

[86]  M. Perucho.  Cancer of the microsatellite mutator phenotype. , 1996, Biological chemistry.

[87]  J. Taylor,et al.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[88]  B. Weiner,et al.  The Influence of Pindolol and Hydrochlorothiazide on Blood Pressure, and Plasma Renin and Plasma Lipid levels , 1986, Journal of clinical pharmacology.

[89]  D. Comings.  Metabolic basis of inherited disease , 1983 .

[90]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[91]  T. Kunkel,et al.  The frameshift infidelity of human DNA polymerase lambda. Implications for function. , 2003, The Journal of biological chemistry.

[92]  F. Hanaoka,et al.  Translesion DNA synthesis catalyzed by human pol eta and pol kappa across 1,N6-ethenodeoxyadenosine. , 2001, The Journal of biological chemistry.

[93]  村松 正道.  Specific expression of activation-induced cytidine deaminase (AID) , a novel member of the RNA editing deaminase family in germinal center B cells , 1999 .

[94]  Ian Tomlinson,et al.  Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog , 1999, Nature medicine.

[95]  Charles R.scriver.  The Metabolic basis of inherited disease , 1989 .

[96]  L. Chang,et al.  Molecular biology of terminal transferase. , 1986, CRC critical reviews in biochemistry.